Featured Research

from universities, journals, and other organizations

Researchers To Test Skeletal Muscle As Replacement For Damaged Human Heart Muscle In Humans

Date:
May 25, 2001
Source:
Duke University
Summary:
After demonstrating in 1998 that muscle cells taken from a rabbit's leg could replace severely damaged heart muscle cells in the animals, Duke University Medical Center researchers plan to see whether their novel approach will work in humans with damaged hearts.

PARIS - After demonstrating in 1998 that muscle cells taken from a rabbit's leg could replace severely damaged heart muscle cells in the animals, Duke University Medical Center researchers plan to see whether their novel approach will work in humans with damaged hearts.

Safety trials set to begin soon at the University Hospital Dykzigt in Rotterdam will be using an approach pioneered by Duke molecular biologist and heart researcher Doris Taylor. Another trial using a different delivery approach is underway at Hospital Bichat in Paris. Taylor said it is likely that similar human trials could begin later this year at Duke and elsewhere in the United States.

In Taylor's approach, muscle cells (myoblasts) are taken from the leg, grown in significant quantities outside the body and then returned to damaged areas of the heart, in this case through a catheter. In all animal models to date, the injected cells have behaved just like heart muscle cells and improved cardiac function.

Taylor outlined the procedure in a "state-of-the-technology" address prepared for delivery Friday at the annual Paris Course on Revascularization, where more than 10,000 European clinicians discussed the latest in cell-based treatments for heart disease. Taylor chronicled how quickly her findings in the laboratory are being translated into clinical trials in humans and how this approach has a major head-start over the latest scientific rage, which uses stem cells to repair ailing hearts in animals.

"Stem cell technology today is where we were with myoblasts five years ago," Taylor said. "While stem cells have an exciting future, there are many challenges to be overcome."

The main differences between the two sources of cells involve quantity and behavior of the cells. Myoblasts can be grown in practically limitless quantities, while there are only finite amounts of stem cells in a potential patient. It is important that cells be taken from the individual whose heart is being repaired to avoid the immune system responses seen in organ transplantation.

"The other major difference is what happens when the cells are actually introduced into the damaged heart," she explained. "Myoblasts quickly start acting like the muscle cells they are and begin contracting like those around them. If stem cells are injected into normal heart, they act like normal heart cells; if they are injected into damaged and scarred heart muscle, they act like damaged or scarred muscle cells."

There is a great need for a new approach to repairing heart damage, Taylor said, since more than 3.5 million people worldwide suffer an acute heart attack each year. Those who survive are usually left with areas of severely damaged heart muscle, which leaves them at risk for further heart attacks. Damaged muscle can also progress to a condition known as congestive heart failure, where the heart gradually loses its ability to pump blood throughout the body.

Taylor envisions that in the near future, a patient would come to the emergency room with a heart attack and doctors would remove a small plug of cells from the leg and grow them in the laboratory for about two to four weeks, which also is long enough to assess damage to the heart. Then the cells would be delivered to damaged areas of the heart with a catheter, a device now commonly used to clear blocked arteries.

Currently there is no way to reverse damage done to the heart during an extended period of low oxygen, as occurs in a severe heart attack. Although the remaining healthy heart muscle cells grow larger to compensate, that only makes the heart more inefficient, ultimately leading to heart failure, which kills more than 410,000 people annually in the United States and Europe.

"Treatments for severe heart failure are currently limited either to making the remaining heart work better or performing a heart transplantation," Taylor said. "You are born with all the heart cells you'll ever have. Once you damage the heart muscle, it's gone forever."

Based on the pre-clinical studies carried out in Taylor's lab at Duke, as well as others in Europe, Taylor is encouraged that a new age of treatment for heart disease is on the horizon.

"This is the first time we actually have a hope for recovery, not just stabilizing and then managing heart patients," Taylor said. "We might actually be able to regain lost heart function, which would improve the quality and quantity of life. Now, only the sickest heart failure patients get heart transplants. With myoblast therapy, there are no limitations on whose quality and quantity of life can be improved."

According to Taylor, should the new approach be shown to be safe and effective in clinical trials, it should become widely available, though every center would not likely be able to handle all aspects of the procedure.

"The process is straightforward, but not simple," she said. "Our clinicians can get cells to anywhere, that's the easier part; growing the cells is more difficult. Unless hospitals want to get into the business of growing cells, it is likely that they will partner with another center or company with that expertise."


Story Source:

The above story is based on materials provided by Duke University. Note: Materials may be edited for content and length.


Cite This Page:

Duke University. "Researchers To Test Skeletal Muscle As Replacement For Damaged Human Heart Muscle In Humans." ScienceDaily. ScienceDaily, 25 May 2001. <www.sciencedaily.com/releases/2001/05/010525071402.htm>.
Duke University. (2001, May 25). Researchers To Test Skeletal Muscle As Replacement For Damaged Human Heart Muscle In Humans. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2001/05/010525071402.htm
Duke University. "Researchers To Test Skeletal Muscle As Replacement For Damaged Human Heart Muscle In Humans." ScienceDaily. www.sciencedaily.com/releases/2001/05/010525071402.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins